Bone Biologics Corporation (BBLG) vs Sunshine Biopharma, Inc. (SBFM)
A side-by-side comparison of Bone Biologics Corporation and Sunshine Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BBLG
Bone Biologics Corporation
$0.47HealthcareDelayed quote: Oct 6, 2026, 2:30 PM EDT
SBFM
Sunshine Biopharma, Inc.
$0.37HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
Total return — BBLG vs SBFM
growth of $100 · dividends reinvested · last 5yBBLG -100.0% (-79.2%/yr)SBFM -100.0% (-87.1%/yr)BBLG compounded faster over this window
Log scale — wide-divergence pair
BBLG SBFM
BBLG vs SBFM: by the numbers
- •SBFM is the larger company ($880215 vs $843637 market cap).
- •Both run net losses; BBLG's is the smaller (0.00% vs -16.50% net margin).
Metrics side by side
Valuation
| Metric | BBLG | SBFM |
|---|---|---|
| P/S ratio | N/A | 0.02 |
| P/B ratio | 0.21 | 0.03 |
Profitability
| Metric | BBLG | SBFM |
|---|---|---|
| Gross margin | 0.00% | 29.80% |
| Operating margin | 0.00% | -14.71% |
| Net margin | 0.00% | -16.50% |
| ROE | -73.66% | -21.18% |
| ROIC | -78.01% | -18.56% |
Growth (annualized)
| Metric | BBLG | SBFM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 203.18% |
Go deeper
Dig into the metrics
Bone Biologics ROESunshine Biopharma ROEBone Biologics operating marginSunshine Biopharma operating marginBone Biologics revenue growthSunshine Biopharma revenue growthBone Biologics free cash flowSunshine Biopharma free cash flow
Bone Biologics & Sunshine Biopharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.